Expression of phosphofructokinase 1 protein and it′s enzyme activity on nasopharyngeal carcinoma
-
摘要: 目的:研究糖酵解途径关键酶磷酸果糖激酶1(PFK1)的蛋白及其酶活性在鼻咽癌活检组织中的表达情况,并探讨其意义。方法:采取病例-对照设计的方法,实验组为41份鼻咽癌患者的鼻咽癌活检组织标本,对照组为20份鼻咽慢性炎性患者的鼻咽部活检组织标本,通过Western blot检测PFK1蛋白的表达;酶学分析的方法检测PFK1酶活性。结果:实验组的 PFK1蛋白表达及其酶活性水平均明显高于对照组(P<0.01);在实验组中,伴有淋巴结转移的鼻咽癌活检标本中的PFK1蛋白及其酶活性表达水平均明显高于无淋巴结转移的鼻咽癌活检标本(P<0.01)。结论:PFK1与鼻咽癌的发生、发展密切相关,可能作为鼻咽癌的肿瘤标志物之一。Abstract: Objective: The aim of this study is to investigate the expression of phosphofructokinase 1 and it's enzyme activity in nasopharyngeal carcinoma biopsy samples.Method: Sixty-one biopsy samples were detected, including 41 tissues from patients with nasopharyngeal carcinoma as experimental group and 20 tissues from patients with chronic nasopharyngitis as control group. Phosphofructokinase 1 protein was detected by Western blot and it's enzyme activity was detected.Result: It was observed that the expression levels of phosphofructokinase 1 protein and it's enzyme activities in the experimental group were higher than that in the control group (P<0.01). In the experimental group, the expression levels of phosphofructokinase 1 protein and it's enzyme activities in patients with lymph node metastasis were higher than that in patients without lymph node metastasis(P<0.01).Conclusion: Phosphofructokinase 1 may be a marker in occurrence and metastasis of nasopharyngeal carcinoma.
-
Key words:
- phosphofructokinase 1 /
- nasopharyngeal neoplasms /
- glycolysis /
- lymph nodes
-
-
[1] CHEN C,YI W,GAO J,et al.Alternative endpoints to the 5-year overall survival and locoregional control for nasopharyngeal carcinoma: A retrospective analysis of 2,450 patients[J]. Mol Clin Oncol,2014,2:385-392.
[2] VANDER HEIDEN M G,CANTLEY L C,THOMPSON C B,et al.Understanding the Warburg effect: the metabolic requirements of cell proliferation[J].Science,2009,324:1029-1033.
[3] LIU S,YAN B,LAI W,et al. As a novel p53 direct target, bidirectional gene HspB2/αB-crystallin regulates the ROS level and Warburg effect[J]. Biochim Biophys Acta,2014,1839:592-603.
[4] ŠMERC A,SODJA E,LEGIŠA M.Posttranslational Modification of 6-phosphofructo-1-kinase as an Important Feature of Cancer Metabolism[J]. PloS One,2011,6:e19645-e19645.
[5] WARBURG O.On the origin of cancer cells[J]. Science,1956,123:309-314.
[6] SÁNCHEZ-ARAGÓ M,FORMENTINI L,CUEZVA J M. Mitochondria-mediated energy adaption in cancer: the H(+)-ATP synthase-geared switch of metabolism in human tumors[J]. Antioxid Redox Signal,2013,19:285-298.
[7] MARÍN-HERNÁNDEZ A, GALLARDO-PÉREZ J C, RODRÍGUEZ-ENRÍQUEZ S,et al. Modeling cancer glycolysis[J]. Biochim Biophys Acta,2011,1807:755-767.
[8] DAS L,VINAYAK M. Long Term Effect of Curcumin in Regulation of Glycolytic Pathway and Angiogenesis via Modulation of Stress Activated Genes in Prevention of Cancer[J].PLoS One,2015,10: e0124000-e0124000.
[9] WEBER G. Enzymology of cancer cells (second of two parts)[J].N Engl J Med,1977,296:541-551.
[10] YUAN Y,GUO-QING P, YAN T,et al. A study of PKM2, PFK-1, and ANT1 expressions in cervical biopsy tissues in China[J].Med Oncol,2012,29:2904-2910.
[11] FUNATO Y,HAYASHI T,IRINO Y,et al. Nucleoredoxin regulates glucose metabolism via phosphofructokinase 1[J].Biochem Biophys Res Commun,2013,440:737-742.
[12] 李烁,杜政德,高进良,等.鼻咽癌组织中6-磷酸果糖激酶-1基因的表达及临床意义[J]. 临床耳鼻咽喉头颈外科杂志,2014,28(6):393-395.
-
计量
- 文章访问数: 238
- PDF下载数: 156